Fig. 8

The therapeutic efficacy of 2D PEG/Cu-BDC nanocatalysts on MDA-MB-231 tumor-bearing mice. a Body weight variations, b relative tumor volumes, c tumor growth rates, d tumor inhibition rates, and f tumor weights of the tumor-bearing mice in different treatment groups (P values: *P < 0.05, **P < 0.01, and ***P < 0.001). e Photographs of the tumors dissected from the tumor-bearing mice after various treatments. g H&E, TUNEL, and Ki-67 staining of the tumor sections in different treatment groups (Scale bars: 50 μm). h H&E staining of the major organs after different treatments (Scale bars: 50 μm)